D
Mineralys Therapeutics, Inc. MLYS
$14.89 $0.2751.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 28.36M 25.78M 23.82M 20.65M 18.30M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 203.07M 201.49M 192.40M 168.35M 134.51M
Operating Income -203.07M -201.49M -192.40M -168.35M -134.51M
Income Before Tax -190.77M -188.51M -177.81M -153.25M -119.67M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -190.77 -188.51 -177.81 -153.25 -119.67
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -190.77M -188.51M -177.81M -153.25M -119.67M
EBIT -203.07M -201.49M -192.40M -168.35M -134.51M
EBITDA -203.01M -201.44M -192.36M -140.61M -80.51M
EPS Basic -3.57 -3.74 -3.64 -3.27 -2.71
Normalized Basic EPS -2.23 -2.33 -2.28 -2.05 -1.69
EPS Diluted -3.57 -3.74 -3.64 -3.27 -2.71
Normalized Diluted EPS -2.23 -2.33 -2.28 -2.05 -1.69
Average Basic Shares Outstanding 218.39M 202.29M 194.03M 184.17M 174.28M
Average Diluted Shares Outstanding 218.39M 202.29M 194.03M 184.17M 174.28M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --